patent/ME-00327-B

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ME-00327-B

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2272808b8fbe6c55e3b0785f77a02217
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-06
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
filingDate	2002-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b853a635147d2863ebb82f165edfe147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a09df2d47f3cc5185a7f156c33b0c3b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b213f886e4f618272f799f727d1af756 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_185327ddc189375f4cfa4db2af98a7b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fefb22a2524b67a31fd286392fbfdde http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f324e04fe38c7ee1b14eb5a6993cb212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6403c5fe51ef09a1f5de0479dc00d690 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bef57281cbf1a31153f98979b798c77
publicationDate	2011-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	ME-00327-B
titleOfInvention	ORAL FORMS OF PROPIVERINE OR ITS PHARMACEUTICALALLY ACCEPTABLE SALTS WITH CONTINUOUS ACTIVE SUBSTANCE RELEASE
abstract	Suitable retardation provides oral pharmaceutical compositions containing propiverine or one or more of its pharmaceutically acceptable salts in an amount of 4 mg to 60 mg of propiverine and having a sustained release of the active substance. Preferably, the mixture of the active substance and, in the case in question, of one or more acidic substances with a pk value of less than 6.65 is provided with a retarding coating or placed in a matrix and this is eventually coated with a further retarding layer.
priorityDate	2001-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4942 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591129

Total number of triples: 51.